Transforming Biopharma
Transforming Biopharma by ZS dissects the complex world of pharmaceuticals through candid conversations. Hosted by Maria Whitman, Transforming Biopharma by ZS covers a variety of perspectives from industry leaders who are pushing boundaries and redesigning the future.
Episodes
26 episodes
How CRM can help pharma break barriers and transform customer engagement
Drive behavior-changing personalized customer engagement at scale by addressing customer barriers with a powerful customer relationship management (CRM) system. ZS experts Omer Hancer, Namita Powers and Srihari Sarangan talk with Maria Whitman ...
•
45:31
Expanding access to cell and gene therapies with McKesson’s Joe DePinto
Joe DePinto, McKesson’s head of cell and gene advanced therapies, supports patients, providers and payers throughout the treatment journey. He’s particularly passionate about helping patients get access to groundbreaking therapeutic interventio...
•
44:23
Future focus: How the AHA is tackling cardiac health and more with Juliana Crawford
If we want to make change in healthcare, we can’t take a one-dimensional approach. We need a multifaceted plan. Having just celebrated its 100th anniversary, the American Heart Association (AHA) is pursuing that vision. Maria Whitman talks with...
•
39:40
Advancing pharma research for everyone: The clinical site perspective
Clinical trial sites are important players in biopharma’s success. In this episode, we hear from site experts Lauren Wall of the University of Chicago and Caroline Smith of Charter Research on how pharma can forge successful partnerships. While...
•
43:08
‘Culture is critical to performance’: Aligning values and strategy with Paul Ingram
What’s the role of culture in an organization and how can it play a pivotal role in shaping performance or even helping businesses transform? Maria Whitman sits down with Paul Ingram, professor of business at Columbia University, to explore the...
•
45:27
Beyond process improvement: Why organizational architecture matters with Mike Tushman
Maria Whitman interviews Mike Tushman, professor at Harvard Business School, about the importance of organizational architecture during times of transformation. He describes how companies that successfully transform create an organizational arc...
•
35:28
Navigating the system, meeting patients where they are with Oya Gilbert
How can healthcare and biopharma meet patients where they are? Maria Whitman interviews Oya Gilbert, a podcaster and patient advocate, about his journey as a multiple myeloma patient. They also talk about Oya’s work with the Health, Hope and Hi...
•
47:45
From data collection to data connection: Reinventing pharma’s commercial model
How can pharma use AI and other technology to deliver a better customer experience? Maria Whitman and a panel of ZS experts discuss pharma’s next-generation commercial model. Carolyn Morrow, Namita Powers, Srihari Sarangan and Karthik Souriraja...
•
42:16
Resetting how we think about obesity: A patient’s point of view
Recent headlines about the use of prescription drugs for weight loss make obesity a prominent and relevant topic in today’s discussions about health and well-being. Bill Coyle, ZS’s global head of biopharma, and Mandi White-Ajmani, Ph.D., clini...
•
42:07
Living with myeloma: Patient advocate Yelak Biru’s story
Yelak Biru, president and CEO of the International Myeloma Foundation, is passionate about patient advocacy with good reason—he’s been one himself for 28 years. Yelak joins Maria Whitman to talk about his patient experience and how it shaped hi...
•
37:56
Disruptors, influencers and the modern customer experience with Arun Shastri
As biopharma transforms its commercial model, what can it learn from other industries? To find out, Maria Whitman sits down with Arun Shastri, global AI practice lead at ZS. Arun’s an expert on how organizations are modernizing their customer e...
•
43:40
On the path to digital transformation with Madhavi Ramakrishna
Madhavi Ramakrishna, global vice president and chief digital officer of commercial, GSK, is passionate about data and technology. A former executive in broadcast media, she’s now at the forefront of adopting analytics to drive commercial su...
•
30:29
‘Patients first, people always’: Science and strategy with Savitri Basavaiah
Savitri Basavaiah, vice president portfolio and commercialization strategy at Janssen, the Pharmaceutical Companies of Johnson & Johnson, has a deep background in biopharma. She joins Maria Whitman to talk about the broader challenges o...
•
Season 2
•
Episode 14
•
26:42
‘Take the risk’: On the frontier of digital therapeutics with Susa Monacelli
Propeller Health brings digital therapeutic expertise together with respiratory care experience to create solutions that improve patients’ lives. General Manager Susa Monacelli joins Maria Whitman to give her perspective on how pharma companies...
•
Season 2
•
Episode 13
•
43:43
Key capabilities for precision medicine with Dennis Flannelly
As head of precision medicine for Merck U.S. Oncology, Dennis Flannelly is thinking ahead. He joins Maria Whitman in this episode to talk about the capability and mindset shifts biopharma needs to make to design, develop and deliver on precisio...
•
Season 2
•
Episode 12
•
16:08
‘Inspired to go above and beyond’: Value creation in precision medicine with Kris Elverum
Biotech CEO/CBO Kris Elverum has worked in large pharma and small biotech firms. He currently acts as a consultant and advisor to both biotech and venture capital companies. Kris joins Maria Whitman on the podcast to share his perspective on pr...
•
Season 2
•
Episode 11
•
32:08
Healthcare from products to patients to policy: The CEO’s view with Pratap Khedkar
What’s on the minds of global healthcare leaders right now? To find out, in this episode Maria Whitman talks with ZS CEO Pratap Khedkar. The company’s top executive since 2021, Pratap is a recognized healthcare thought leader with expertise...
•
Season 1
•
Episode 10
•
38:35
‘I have MS; MS doesn’t have me’: Anita’s story
Anita Cameron has been living with multiple sclerosis (MS) for more than 30 years. But her condition hasn’t stopped her from learning all she can about MS and the treatments available to her. Anita tells Maria about her patient journey and the ...
•
Season 1
•
Episode 9
•
29:11
‘We all have to be at the table’: Action for health equity with Josette Gbemudu
On this episode of Transforming Biopharma, Maria Whitman hears from Josette Gbemudu, executive director of health equity and social determinants of health at Merck, about how the company is taking action to make its vision of health equity a re...
•
Season 1
•
Episode 8
•
35:47
‘We can use this data for good’: Flatiron Health CEO Carolyn Starrett
Founded in 2012, Flatiron Health helps cancer centers to thrive and deliver better care for patients. CEO Carolyn Starrett joins Maria Whitman to talk about reimagining the infrastructure that supports cancer care and research around the world....
•
Season 1
•
Episode 7
•
30:13
A deeper dive into ZS’s connected health research with Rob Jekielek
ZS worked with The Harris Poll to conduct its latest research on the future of health. In this episode, host Maria Whitman welcomes Rob Jekielek, managing director at The Harris Poll and a globally recognized expert on business, societal, techn...
•
26:54
Listening to the patient: Robin’s story of cancer and recovery
Meet Robin Ameny, a passionate patient advocate and a survivor of multiple myeloma. In this episode, host Maria Whitman invites us to see the patient journey through Robin’s eyes. Hear how Robin found the courage to advocate for herself as she ...
•
Season 1
•
Episode 5
•
28:52
Leading through transformation with Dr. Linda Hill
Dr. Linda Hill, Ph.D., a professor at the Harvard Business School, has advised a number of organizations in the process of digital transformation. The co-author of “Collective Genius: The Art and Practice of Leading Innovation” and “Being the B...
•
45:50
Data as an asset: From real-world evidence to actionable insights with Dr. Aarti Shah
Dr. Aarti Shah, former senior vice president and chief information and digital officer at Eli Lilly & Company, knows pharma and technology inside and out. At Eli Lilly, she led an enterprise-wide global organization with responsibilities fo...
•
Season 1
•
Episode 3
•
32:45
The state of digital health: What’s next for consumers and biopharma with Ahmed Albaiti
When we use the terms digital health or digital medicine, what do we really mean? Host Maria Whitman takes up this question with Ahmed Albaiti, Head of Digital and Connected Health at ZS. Albaiti, who previously founded and led Medullan, has mo...
•
30:48